Dr. Julie Gralow on the Importance of Genetic Testing for Breast Cancer
Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, talks about the importance of women knowing which genetic tests they�ve previously had done for breast cancer.
Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, talks about the importance of women knowing which genetic tests they’ve previously had done for breast cancer. Of patients that have had standard genetic testing and then been referred back for multi-gene testing, 13% of them found a different mutation than they had initially aware of.
Gralow also touches on how genetic testing is increasingly helpful for catching breast cancer in women with a familial high risk of developing the disease.
Therapy Changes for Metastases and Toxicity Discussed in Breast Cancer
September 5th 2024During a Case-Based Roundtable® event, Ian Krop, MD, PhD, and event participants discussed how different types of metastases and treatment toxicity would affect therapy given to patients with triple-positive breast cancer in the second article of a 2-part series.
Read More
